← 홈

ADC

1,068개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,068개
ADCBiologicSeagenvedotin-containing regimen …Phase 2

Adcetris (Brentuximab vedotin, Brentuximab vedotin (Adcetris))

Anaplastic Large Cell Lymphoma, ALK-Positive · Anaplastic Large Cell Lymphoma, ALK-Posi

#AnaplasticLargeCellLymphomaALK-P#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 89.5%임상시험 51상태 RECRUITING
ADCBiologicPfizerPhase 1

CPX-351 (CPX-351)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase1#인기#항체약물접합체+3
효능 ORR 22%임상시험 51상태 DISCONTINUED
ADCBiologicUNICANCERPhase 2

Copanlisib (Copanlisib)

Carcinoma, Squamous Cell of Head and Neck · FRα

#FR#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 51상태 DISCONTINUED
ADCBiologicBristol-Myers SquibbPhase 2

Luspatercept (Luspatercept)

Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+5
임상시험 51상태 RECRUITING
ADCBiologicRemeGen Co., Ltd.vedotin (RC48) with the est…Phase 3

disitamab vedotin (Disitamab Vedotin, RC48, RC48-ADC)

Salivary Gland Tumors · Urothelial Carcinoma

#UrothelialCarcinoma#ADC#Phase3#인기#항체약물접합체+5
임상시험 51상태 ACTIVE
ADCBiologicAmgenbiodistributionPhase 2

Sotorasib (Sotorasib)

Colorectal Cancer; Resectable Colorectal Carcinoma · Locally Advanced Lung Non-Small Cell Car

#LocallyAdvancedLungNon-SmallCell#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 0%임상시험 51상태 RECRUITING
ADCBiologicAstraZenecaderuxtecan or sacituzumab g…Phase 2

Capivasertib (Capivasertib)

Metastatic Breast Cancer · FRα

#FR#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 56.5%임상시험 50상태 RECRUITING
ADCBiologicSWOG Cancer Research Networkderuxtecan (T-DXd) and tyro…Phase 3

Cyclin-Dependent Kinase 4 Inhibitor (Cyclin-Dependent Kinase 4 Inhibitor)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic HER2-Positive Breast Carcinoma · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 57.98%임상시험 50상태 RECRUITING
ADCBiologicAstex Pharmaceuticals, Inc.Phase 2

Decitabine and Cedazuridine (Decitabine and Cedazuridine)

Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8 · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 0%임상시험 50상태 RECRUITING
ADCBiologicHoffmann-La RochePhase 2

Entinostat (Entinostat)

Breast Neoplasms · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 22.2%임상시험 50상태 DISCONTINUED
ADCBiologicAstraZenecaderuxtecan plus fluoropyrim…Phase 3

FLOT Chemotherapy (FLOT Chemotherapy)

Gastrointestinal Neoplasms; Esophagogastric Junction · Gastroesophageal Adenocarcinoma

#GastroesophagealAdenocarcinoma#ADC#Phase3#인기#항체약물접합체+5
임상시험 50상태 RECRUITING
ADCBiologicMerckvedotin after avelumabPhase 2

PEV (Pembrolizumab & Enfortumab Vedotin, Pembrolizumab & Enfortumab Vedotin (PEV))

Urothelial Carcinoma · Urothelial Carcinoma

#UrothelialCarcinoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 15.6%임상시험 50상태 RECRUITING
ADCBiologicAstellas Pharma Incvedotin after avelumabPhase 1

Enfortumab (Enfortumab)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 15.6%임상시험 49상태 ACTIVE
ADCBiologicAstellas Pharma Global Developm…Phase 2

Gilteritinib (Gilteritinib)

Acute Myeloid Leukemia (AML); Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 33.3%임상시험 49상태 RECRUITING
ADCBiologicMedImmune LLCvedotin combined with cispl…Phase 2

DHAP (DHAP)

Diffuse Large B-Cell Lymphoma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 47.5%임상시험 48상태 ACTIVE
ADCBiologicFondazione per la Medicina Pers…Phase 2

Itacitinib (Itacitinib)

Breast Cancer; Gastrointestinal Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 93%임상시험 48상태 ACTIVE
ADCBBiologicADC TherapeuticsthatPhase 2

Anti-CD19 Antibody-Drug Conjugate (Loncastuximab Tesirine, Loncastuximab Tesirine (Anti-CD19 Antibody-Drug Conjugate))

Diffuse Large B-Cell Lymphoma; High-grade B-cell Lymphoma (HGBCL) · CD19

#CD19#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 94.1%임상시험 48상태 RECRUITING
ADCBiologicPharmaMarderuxtecan in patients with…Phase 3

Lurbinectedin (Lurbinectedin)

Small-cell Lung Cancer; Relapsed Small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+5
효능 ORR 40.7%임상시험 48상태 RECRUITING
ADCBiologicStrata OncologyPhase 2

encorafenib + binimetinib (encorafenib + binimetinib)

Cancer; Advanced Solid Tumor · Cancer

#Cancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 66.7%임상시험 48상태 DISCONTINUED
ADCBiologicSWOG Cancer Research NetworkPhase 3

Cyclin-Dependent Kinase 6 Inhibitor (Cyclin-Dependent Kinase 6 Inhibitor)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic HER2-Positive Breast Carcinoma · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 24%임상시험 47상태 RECRUITING

12 / 54 페이지

← 이전다음 →